“…Therefore, the use of angiogenic inhibitors in order to reduce tumor metastasis is a promising method for treating tumors (O'Reilly et al, 1994;Konno et al, 1995;Zetter, 1998;Ebos et al, 2009;Pàez-Ribes et al, 2009). Prostate cancer is related to angiogenesis and vascular invasion and thus inhibition of angiogenesis can be used as a method to treat prostate cancers (Weidner et al, 1993;Bagley et al, 2011;Gyftopoulos et al, 2011;Assadian et al, 2012;Lynch et al, 2012;Pande et al, 2012;Pinto et al, 2012). We previously found that ApoG2, a gossypol derivative, inhibits proliferation of prostate cancer cells both in vitro and in vivo and induces their apoptosis and autophagy (Zhang et al, 2010a;Zhang et al, 2010b).…”